User profiles for Utkarsh Agrawal

Utkarsh Agrawal

- Verified email at phc.ox.ac.uk - Cited by 2693

Utkarsh Agrawal

- Verified email at kitp.ucsb.edu - Cited by 347

Generalized hydrodynamics, quasiparticle diffusion, and anomalous local relaxation in random integrable spin chains

U Agrawal, S Gopalakrishnan, R Vasseur - Physical Review B, 2019 - APS
We study the nonequilibrium dynamics of random spin chains that remain integrable (ie,
solvable via Bethe ansatz): because of correlations in the disorder, these systems escape …

[HTML][HTML] Two-dose ChAdOx1 nCoV-19 vaccine protection against COVID-19 hospital admissions and deaths over time: a retrospective, population-based cohort study …

…, V Boaventura, GL Werneck, R Flores-Ortiz, U Agrawal… - The Lancet, 2022 - thelancet.com
Background Reports suggest that COVID-19 vaccine effectiveness is decreasing, but whether
this reflects waning or new SARS-CoV-2 variants—especially delta (B.1.617.2)—is unclear…

Noninteger-spin magnonic excitations in untextured magnets

A Kamra, U Agrawal, W Belzig - Physical Review B, 2017 - APS
Interactions are responsible for intriguing physics, eg, the emergence of exotic ground states
and excitations, in a wide range of systems. Here, we theoretically demonstrate that dipole-…

[HTML][HTML] Interim findings from first-dose mass COVID-19 vaccination roll-out and COVID-19 hospital admissions in Scotland: a national prospective cohort study

E Vasileiou, CR Simpson, T Shi, S Kerr, U Agrawal… - The Lancet, 2021 - thelancet.com
Background The BNT162b2 mRNA (Pfizer–BioNTech) and ChAdOx1 nCoV-19 (Oxford–AstraZeneca)
COVID-19 vaccines have shown high efficacy against disease in phase 3 clinical …

Optimized Binary Bat algorithm for classification of white blood cells

D Gupta, J Arora, U Agrawal, A Khanna… - Measurement, 2019 - Elsevier
The quantitative and differential analysis of leukocytes present in human body provide conducive
hematological information to physicians for diagnosis of various infections and ailments…

[HTML][HTML] Informing the public health response to COVID-19: a systematic review of risk factors for disease, severity, and mortality

…, CR Simpson, MD Muckian, U Agrawal… - BMC infectious …, 2021 - Springer
Background Severe Acute Respiratory Syndrome coronavirus-2 (SARS-CoV-2) has challenged
public health agencies globally. In order to effectively target government responses, it is …

[HTML][HTML] Effectiveness of first dose of COVID-19 vaccines against hospital admissions in Scotland: national prospective cohort study of 5.4 million people

…, CR Simpson, C Robertson, T Shi, S Kerr, U Agrawal… - 2021 - papers.ssrn.com
Background: The BNT162b2 mRNA (Pfizer-BioNTech) and ChAdOx1 (Oxford-AstraZeneca)
COVID-19 vaccines have demonstrated high efficacy against infection in phase 3 clinical …

[HTML][HTML] SARS-CoV-2 infection and COVID-19 vaccination rates in pregnant women in Scotland

…, T McLaughlin, J Pan, T Shi, B Taylor, U Agrawal… - Nature medicine, 2022 - nature.com
Population-level data on COVID-19 vaccine uptake in pregnancy and SARS-CoV-2 infection
outcomes are lacking. We describe COVID-19 vaccine uptake and SARS-CoV-2 infection in …

[HTML][HTML] First-dose ChAdOx1 and BNT162b2 COVID-19 vaccines and thrombocytopenic, thromboembolic and hemorrhagic events in Scotland

…, S Kerr, E Moore, C McCowan, U Agrawal… - Nature medicine, 2021 - nature.com
Reports of ChAdOx1 vaccine–associated thrombocytopenia and vascular adverse events
have led to some countries restricting its use. Using a national prospective cohort, we …

[HTML][HTML] Severe COVID-19 outcomes after full vaccination of primary schedule and initial boosters: pooled analysis of national prospective cohort studies of 30 million …

U Agrawal, S Bedston, C McCowan, J Oke, L Patterson… - The Lancet, 2022 - thelancet.com
Background Current UK vaccination policy is to offer future COVID-19 booster doses to
individuals at high risk of serious illness from COVID-19, but it is still uncertain which groups of …